The Role of Immunotherapy in Treating Ovarian Cancer: A Promising Frontier in Cancer Care
The ovarian cancer drug market, which was valued at USD 2,678.00 million in 2022, is predicted to grow to USD 7,423.00 million by 2030, with a CAGR of 14.3%.
The ovarian cancer drug market, which was valued at USD 2,678.00 million in 2022, is predicted to grow to USD 7,423.00 million by 2030, with a CAGR of 14.3%.